USPTO serial 79337353
ZUTRA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 13, 2023
- Examiner
- NOVAKOVIC, MIROSLAV
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ZUTRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marlene J. Williams
Marlene J. Williams Buchalter, APC425 Market StreetSuite 2900San Francisco, CA 94105-2491Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Nutraceuticals for use as a dietary supplement; nutraceuticals for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; nutraceuticals for medical purposes, specifically, for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; dietary supplements; vitamins; herbal supplements; mineral supplements; dietary food supplements for medical use; dietary foods for medical use, namely, nutritional drinks, supplemental drinks and powdered dietary food supplements; dietary nutritional supplements for medical use; dietary supplements for humans; dietary supplements for humans and animals; dietary supplements for medical use; food supplements for the dietary management of illness in humans; oils for use as a dietary supplement, namely, krill oil and mussel oil; powders for use as a dietary supplement, namely, mussel powder; calcium supplements; vitamins for humans and animals; dietary supplements for animals and pets; pharmaceutical preparations and substances for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; pharmaceutical preparations and substances containing fish oils for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; dietetic food and beverages adapted for medical use; cod liver oil; nutritional supplements; vitamin and mineral supplements; nutritional supplements containing vitamins, minerals, trace elements and/or essential fatty acids including fish oils, provided in capsule, solid, liquid or tablet form; nutritional complements in the nature of nutritional supplements for medical use; preparations in the nature of vitamin and mineral supplements consisting of minerals, vitamins, trace elements and/or essential fatty acids including fish oils for use as additives for food; slimming aids and preparations in the nature of slimming pills for medical use including meal replacement preparations in capsule, liquid or gel form; antibiotics; anti-inflammatory preparations and balms for medical purposes; nutritional preparations and substances in the nature of nutritional supplements adapted for medical use; edible oils and fats adapted for medical use, namely, edible fish oil; dietetic foods and food preparations adapted for medical use, namely, nutritional drinks, supplemental drinks and powdered dietary food supplements; dietetic beverages and drinks adapted for medical use; dietary supplements; food supplements; mineral food supplements; mineral water salts for medical purposes; mineral water for medicinal use; nutritional additives in the nature of dietary supplements for medical use; medicinal oils; medicinal preparations and food supplements for slimming purposes; vitamin and mineral preparations, supplements and substances adapted for medical use; veterinary preparations and substances including those containing fish oil for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; sanitary preparations and substances including those containing fish oils for medical use | ACTIVE | — |
| 029 | Prepared and packaged meals consisting primarily of processed fish, seafood or algae in liquid, solid, gel or liquid form for human consumption; dried milk and rice based meal replacement preparations not for medical purposes, namely rice milk, rice milk powder in liquid, solid, gel or liquid form; health foods and food supplements not for medical purposes, namely, prepared and packaged meals consisting primarily of preserved, dried, and cooked vegetables, fruit, nut or meat; snack foods, namely, snack bars, chilled foods, oils for food, food pastes, frozen meals and tinned food consisting primarily of preserved, dried, and cooked vegetables, fruit, nut or meat; foodstuffs rich in proteins, based on meat, fish, vegetables and dairy for human consumption, namely, snack bars, chilled foods, oils for food, food pastes, frozen meals and tinned food; preserved, dried and cooked fruits, nuts and vegetables; edible oils and fats; extracts of processed fish, shellfish or algae for nutritional purposes, specifically for use in prepared meals or food; fruit preserves; instant meals in the nature of prepared and pre-packaged meals consisting primarily of preserved, dried, and cooked vegetables, fruit, nut or meat | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OPTICA LIFE ACCESSORIES LIMITED
- Other trademarks owned by OPTICA LIFE ACCESSORIES LIMITED
- Other trademarks owned by OPTICA LIFE ACCESSORIES LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 029
- Similar marks named ZUTRA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 5, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 10, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 18, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 18, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 13, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 13, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 13, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 21, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 21, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 21, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 21, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 21, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 21, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 21, 2023 | PBER | WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST | — |
| Feb 21, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 21, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 21, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 21, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 21, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 9, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Dec 17, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 16, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 5, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 4, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |